oral semaglutide fda approval Approves as the First Oral GLP-1 Pill The FDA has officially approved
Description
Orforglipron pill $149.
Full breakdown: | 15 comments on LinkedIn

Semaglutide can reduce the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), study results have revealed

FDA-approved GLP-1 medication offering proven weight loss results
